The Japanese investment holding company SoftBank Group ( OTCPK:SFTBY) purchased two new stakes: 20.45M shares in Pacific Biosciences of California ( PACB ), and 14.66M shares in Recursion ...
As shown, with Crexendo’s levered FCF margin of 13.2% and its current WACC, the stock still has ample upside potential.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback